Freeline Therapeutics (FRLN) News Today

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Ownership Short Interest Social Media

Source

Source	Headline
	Freeline Therapeutics Stock (NASDAQ:FRLN) Dividends: History, Yield and Dates benzinga.com - February 25 at 9:46 AM
	Acquisition of Freeline by Syncona Becomes Effective finance.yahoo.com - February 20 at 7:47 AM
	Acquisition of Freeline by Syncona Becomes Effective globenewswire.com - February 20 at 7:00 AM
	marketbeat.com - February 19 at 6:09 AM
	Freeline Therapeutics Shareholders Approve Acquisition by Syncona finanznachrichten.de - February 13 at 8:31 AM
	Freeline Shareholders Approve Acquisition by Syncona finance.yahoo.com - February 12 at 3:18 PM
	Freeline Therapeutics Holdings plc (FRLN) uk.finance.yahoo.com - February 9 at 1:47 PM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SRC, EAR, PATI, FRLN markets.businessinsider.com - December 1 at 7:40 PM
	Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX) and Freeline Therapeutics Holdings (FRLN) markets.businessinsider.com - November 30 at 1:46 PM
	FREELINE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline ... businesswire.com - November 29 at 6:29 AM
	Freeline (FRLN) Shares Rise on Merger Agreement With Syncona finance.yahoo.com - November 23 at 12:34 PM
	Syncona Limited to Acquire Freeline Therapeutics finanznachrichten.de - November 22 at 3:30 PM
	FRLN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Freeline Therapeutics Holdings plc Is Fair to Shareholders tmcnet.com - November 22 at 10:30 AM
	marketbeat.com - November 22 at 7:25 AM
	FRLN Freeline Therapeutics Holdings plc seekingalpha.com - November 18 at 8:14 AM
	marketbeat.com - November 6 at 10:14 AM
	Freeline Therapeutics Holdings PLC ADR FRLN morningstar.com - November 5 at 10:47 PM
	Freeline Therapeutics: Promising Initial Efficacy Data and Potential for High Revenues Justify Buy Rating markets.businessinsider.com - October 28 at 7:04 AM
	Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress finance.yahoo.com - October 25 at 9:34 AM
	Here's Why We're A Bit Worried About Freeline Therapeutics Holdings' (NASDAQ:FRLN) Cash Burn Situation finance.yahoo.com - October 19 at 9:05 AM
	Where Freeline Therapeutics Stands With Analysts markets.businessinsider.com - October 18 at 6:53 PM
	Freeline to Present New Clinical Data for FLT201 in Gaucher Disease in Oral Presentation at Upcoming ESGCT 30th Annual Congress finance.yahoo.com - October 16 at 9:41 AM
	Freeline Therapeutics ADRs Rise 14% Following Positive Trial Data on FLT201 marketwatch.com - October 6 at 7:11 PM
	Promising Gaucher Disease Trial Results and Potential Parkinson’s Disease Impact Bolster Analyst’s Buy Rating for Freeline Therapeutics Holdings markets.businessinsider.com - October 5 at 9:30 AM
	Why Is Gene Therapy Player Freeline Therapeutics Stock Trading Higher Today? benzinga.com - October 4 at 11:02 AM
	Freeline Reports Positive Data From First Cohort Of Phase 1/2 GALILEO-1 Trial Of FLT201 markets.businessinsider.com - October 4 at 9:48 AM
	Freeline Reports Positive Initial Clinical Data from First Cohort of Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease finance.yahoo.com - October 4 at 9:48 AM
	H.C. Wainwright Sticks to Their Buy Rating for Freeline Therapeutics Holdings (FRLN) markets.businessinsider.com - August 17 at 10:05 AM
	Freeline Therapeutics Holdings plc (NASDAQ:FRLN) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 17 at 10:05 AM
	4 Analysts Have This to Say About Freeline Therapeutics markets.businessinsider.com - August 16 at 5:27 PM
	Q2 2023 Freeline Therapeutics Holdings PLC Earnings Call finance.yahoo.com - August 16 at 3:38 AM
	Freeline Therapeutics GAAP EPS of -$0.23 beats by $3.28, revenue of $0.62M seekingalpha.com - August 15 at 5:36 PM
	Freeline Therapeutics Holdings plc: Freeline Reports Second Quarter 2023 Financial Results and Business Highlights finanznachrichten.de - August 15 at 8:30 AM
	Freeline Reports Second Quarter 2023 Financial Results and Business Highlights finance.yahoo.com - August 15 at 8:30 AM
	Freeline Therapeutics's Earnings: A Preview benzinga.com - August 14 at 5:29 PM
	Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call finance.yahoo.com - August 8 at 8:47 AM
	Freeline to Host Virtual KOL Event on its Gene Therapy Candidate, FLT201, in Gaucher Disease finance.yahoo.com - July 25 at 10:28 AM
	Freeline Therapeutics Holdings plc thestreet.com - July 20 at 1:46 PM
	marketbeat.com - July 14 at 2:31 PM
	Freeline Therapeutics Holdings Shares Halted On Circuit Breaker To The Upside, Up 53.1% benzinga.com - July 13 at 10:10 AM
	Estimating The Fair Value Of Freeline Therapeutics Holdings plc (NASDAQ:FRLN) finance.yahoo.com - July 13 at 10:10 AM
	marketbeat.com - July 12 at 10:43 AM
	marketbeat.com - July 12 at 10:31 AM
	marketbeat.com - July 12 at 10:24 AM
	marketbeat.com - July 12 at 10:09 AM
	marketbeat.com - July 12 at 9:45 AM
	marketbeat.com - July 12 at 9:35 AM
	Freeline Announces First Patient Dosed with Its Novel tmcnet.com - June 26 at 3:34 PM
	Freeline Announces First Patient Dosed with Its Novel Gene Therapy Candidate for Gaucher Disease and Unveils Research Program in GBA1-linked Parkinson’s Disease finance.yahoo.com - June 26 at 8:47 AM
	Freeline Therapeutics Holdings PLC Sponsored ADR (FRLN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now finance.yahoo.com - June 13 at 4:36 PM

Get Freeline Therapeutics News Delivered to You Automatically

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

FRLN Media Mentions By Week

FRLN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FRLN
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

FRLN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FRLN Articles
This Week
▼
0

1
▲
FRLN Articles
Average Week

Get Freeline Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:FRLN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Freeline Therapeutics (FRLN) News Today

FRLN Media Mentions By Week

FRLN Media Sentiment

FRLN News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info